The efficiency of the interaction between MHC-II-peptide complexes (pMHC-II) and T cell receptor depends on the amount of antigen present at the surface of DCs. MHC-II molecules are constitutively present in plasma membrane lipid rafts, membrane microdomains that are important to induce T cell activation at low antigen doses. In this work we investigated if DCs can possess a specific pMHC-II distribution at the surface that can enhance T cell activation. In murine bone marrow derived mature DCs (mDCs), MHC-II molecules displayed a clustured phenotype. Using an antibody that recognizes specific IAk-HEL pMHC-II complexes, we observed that pMHC-II also showed a clustered distribution on the surface of antigen-loaded mDCs. While DCs treated with LPS for only 12 h had 50% less IAk-HEL pMHC-II complexes at the cell surface than DCs treated for 30 h, both cell types showed a clustured distribution of these complexes. Despite the fact that 12 h DCs expressed less IAk-HEL pMHC-II complexes and less CD86/CD40 molecules at the cell surface, T cell activation was similar using 12 h- or 30 h-mature DCs. We are currently investigating the relationship between pMHC-II complex number and cluster distribution over time with the antigen presenting cell function to elucidate the role of microdomain association of pMHC-II in T cell activation.
This work is supported by NCI.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.